International Experts in Attention Deficit Hyperactivity Disorder (ADHD) Take
New Professional Society Formed to Improve the Quality of Care for People with ADHD
June 1, 2009 – A new international organization called The American Professional Society of ADHD and Related Disorders (APSARD) is the first based in the U.S. to focus exclusively on ADHD, a complex and serious neuro-developmental condition. Led by a diverse Board consisting of global experts in fields such as psychiatry, epidemiology, ethics, coaching, and pediatrics, APSARD’s goal is to improve the quality of care for patients with ADHD, from childhood through adulthood, through the exchange of research, best
practices, and evidence-based insights. The first issue of the Journal of ADHD and Related Disorders (JARD), APSARD’s quarterly, clinically-oriented, peer-reviewed Journal, will be launched in June 2009.
Hundreds of millions of people worldwide have ADHD, causing social, emotional, and financial burdens to patients and the lives they touch – family, friends, co-workers, and healthcare systems. ADHD affects approximately three to five percent of children, with symptoms persisting in 75 percent of adolescents and 50 to 60 percent of adults. Given this lifelong persistence of symptoms, and the fact that only 10 to 25 percent of adults are treated for ADHD, it is critical that healthcare professionals are properly educated and trained to ensure effective and continuous patient care.
“There is significant need for increased medical education about recognizing, assessing and treating ADHD, especially in adults, and this is on the top of APSARD’s agenda,” said Lenard Adler, M.D., President of APSARD and Professor of Psychiatry and Child and Adolescent Psychiatry, New York School of Medicine. “APSARD will also work with ADHD patient organizations to heighten the public’s understanding of ADHD to reduce stigma and further promote effective dialogue between healthcare professionals and patients.”
Diagnosing and treating ADHD can be complicated due to patient heterogeneity, including the wide- ranging number of co-existing cognitive, behavioral, and neurological conditions, such as substance
abuse, bipolar disorder, anxiety, depression, obsessive compulsive disorder, and Tourette syndrome. “It’s imperative to determine a primary diagnosis of ADHD so healthcare professionals can work with patients on an effective symptom management plan,” said Dr. Adler.
For its members, comprised of a broad spectrum of allied mental health professionals, APSARD will offer a range of services including a comprehensive Web site (www.apsard.org), an annual scientific meeting, its quarterly, peer-reviewed journal, and the development of guidelines that address diagnosis, assessment and treatment of ADHD across the lifespan.
About the Journal of ADHD and Related Disorders (JARD)
JARD will cover the latest advances in ADHD with articles that focus on awareness, clinical care, and advancing therapy for adult and pediatric patients with ADHD and related disorders. Through high quality research studies, review articles and meta-analysis of prior literature, JARD provides a forum for exchanging information on best practices and effective treatment strategies for different patient populations and patient education.
Manuscripts are welcome on a variety of topics including screening, diagnostic and assessment strategies, therapeutic options including abuse and misuse of medications, epidemiology and genetics, neuropsychology and neuroimaging, health service utilization and functional impairment. For author guidelines or to subscribe, visit www.apsard.org.
APSARD has secured funding from a variety of sources including private donations, membership, and industry. APSARD is committed to full transparency and disclosure to ensure high ethical standards and scientific rigor. APSARD is also reviewing the recent Institute of Medicine’s recommendations to prevent conflicts of interest so that it can ensure the society is in general compliance.
Examples of this commitment include the institution of a diverse, esteemed Board; a comprehensive Code of Ethics; Board disclosure statements on its Web site, and a conflict of interest policy.